Alendronate clinical trials
Also written Fosamax, MK0217 and Alendronic acid.
How each study uses Alendronate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Alendronate studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 29 Sept 1995 · FOSAMAX · NDA 020560 (FDA, Drugs@FDA)
- European Union
- 24 Aug 2005 · Fosavance · EMEA/H/C/000619 (EMA; in a combination)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
90 studies that test it; most in 2006 (7)
| Year | Studies |
|---|---|
| 1997 | 1 |
| 1998 | 5 |
| 1999 | 5 |
| 2000 | 3 |
| 2001 | 2 |
| 2002 | 5 |
| 2003 | 6 |
| 2004 | 2 |
| 2005 | 6 |
| 2006 | 7 |
| 2007 | 6 |
| 2008 | 4 |
| 2009 | 4 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 4 |
| 2013 | 1 |
| 2014 | 7 |
| 2015 | 4 |
| 2016 | 3 |
| 2018 | 2 |
| 2019 | 1 |
| 2022 | 3 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 14 · Other 77
Massachusetts General Hospital (5) · Organon and Co (5) · Columbia University (4) · National Institute of Allergy and Infectious Diseases (NIAID) (3) · Government Dental College and Research Institute, Bangalore (3) · National Taiwan University Hospital (2) · Medical University of South Carolina (2) · Chinese University of Hong Kong (2)
Often tested with
Tested in the same studies.
Teriparatide (7) · Zoledronic Acid (4) · Vitamin D (4) · Denosumab (4) · Cholecalciferol (3) · Ibandronic Acid (3) · Raloxifene (2) · Metformin (1)
Related medicines
As reviewed, each with the page that says it.
- One of Diphosphonates source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 3
Studies that test Alendronate.
- Jan 2027Novel Precision Medicine Approach to Treatment of Osteoporosis Based on Bone TurnoverPhase 4 · Madhumathi Rao
- Mar 2027Small Trial of Alendronate Impact on the Reservoir of HIVPhase 2 · National Institute of Allergy and Infectious Diseases (NIAID)
- Sep 2027Alendronate for Osteonecrosis in Adults With Sickle Cell DiseasePhase 2 · University of California, Davis
Studies
Open first, then newest update. How each study uses Alendronate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 91
- Small Trial of Alendronate Impact on the Reservoir of HIVRecruitingPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT07216794Written as Alendronate
- A Multi-centre, Double-blind RCT to Investigate the Effect of Alendronate on Knee Function Following ACLRRecruitingPhase 4Chinese University of Hong KongNCT05527548Written as Alendronate (ALN)
- Alendronate for Osteonecrosis in Adults With Sickle Cell DiseaseRecruitingPhase 2University of California, DavisNCT06016634Written as Alendronate Sodium
- Precision Medicine Approach for Osteoporosis - Follow Up StudyEnrolling by invitationPhase 4Paul F NetzelNCT06264609Written as Alendronate
- Alendronate to Reduce Pelvic Insufficiency Fractures in Cervical Cancer Patients Undergoing ChemoradiationNot yet recruitingPhase 1/2Dr. Itay GoorAryehNCT07245381Written as Alendronate 70mg weekly
- A Clinical Study on the Effect of Discontinuing Alendronate in Postmenopausal Women With Osteoporosis After a Treatment Period Without FracturesRecruitingPhase 4Odense University HospitalNCT06864130Written as Alendronate 70mg weekly
- Novel Precision Medicine Approach to Treatment of Osteoporosis Based on Bone TurnoverActive, not recruitingPhase 4Madhumathi RaoNCT05151484Written as Alendronate
- Efficacy of Alendronate Versus Placebo in the Treatment of HIV-associated Osteoporosis (ANRS120)CompletedPhase 3French National Agency for Research on AIDS and Viral HepatitisNCT00120757Written as Alendronate
- The Optimal Sequential Therapy After Long Term Denosumab TreatmentCompletedPhase 4National Taiwan University HospitalNCT05091099Written as Alendronate and Zoledronate
- Clinical Efficacy of 1% Metformin and Alendronate Gel in Adjunct to Fibrin in Chronic PeriodontitisActive, not recruitingPhase 4Bahria UniversityNCT06856369Written as alendronate sodium powder
- A Study to Evaluate the Drug-Drug Interaction Between Enlicitide Decanoate (MK-0616) and Alendronate in Healthy Adult Participants (MK-0616-027)CompletedPhase 1Merck Sharp & Dohme LLCNCT06772792Written as Alendronate
- A Research Study to Test the Effectiveness of MK0217 in Patients With Paget's Bone Disease (0217-206)(COMPLETED)CompletedPhase 3Organon and CoNCT00480662Written as alendronate
- A Study to Evaluate and Compare Alendronate and Risedronate on Bone Mineral Density in Women With Postmenopausal Osteoporosis (MK-0217-211)CompletedPhase 3Organon and CoNCT00092014Written as Alendronate
- Bisphosphonates for Prevention of Post-Denosumab Bone LossCompletedPhase 2Columbia UniversityNCT03396315Written as Alendronate
- Efficacy and Safety Study of Fosamax Plus D in Postmenopausal Women With Osteoporosis (0217A-263)CompletedPhase 4Organon and CoNCT00729651Written as alendronate sodium (+) cholecalciferol
- Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate CancerTerminatedPhase 2National Cancer Institute (NCI)NCT00019695Written as alendronate sodium
- Alendronate Treatment of Osteoporosis in Rheumatoid ArthritisCompletedPhase 2University of AarhusNCT02944799Written as Alendronate
- Testosterone and Alendronate in Hypogonadal MenTerminatedPhase 2Massachusetts General HospitalNCT01460654Written as Alendronate
- Effects of Zoledronic Acid Versus Alendronate on Bone Loss After Kidney and Kidney/Pancreas TransplantsCompletedNot applicableUniversity of NebraskaNCT00580047Written as Alendronate
- Comparative Antiresorptive Efficacy Discontinuation of DenosumabActive, not recruitingPhase 4Massachusetts General HospitalNCT03623633Written as alendronate
See all 91 studies that test Alendronate →
Given beside what is tested · 8 — Alendronate is usual care or a partner of the new treatment
- Clinical Study Evaluating Beta Blockers Use and Fracture Risk in Patients With Primary OsteoporosisRecruitingPhase 3Sherief Abd-ElsalamNCT04704947Written as alendronate sodium
- Therapeutic Prospects of HMG-CoA Reductase Inhibitors, Atorvastatin and Rosuvastatin, in Osteoporotic PatientsCompletedNot applicableAlkufa university\\collage of pharmacyNCT07717788Written as Alendronate 70 mg tablets
- Effects of Denosumab on Bone Mineral Density in Women With Anorexia Nervosa: A Pilot StudyCompletedPhase 3Massachusetts General HospitalNCT03292146Written as Alendronate 70Mg Tab
- Romosozumab in Women With Chronic SCICompletedPhase 2Northwestern UniversityNCT04708886Written as Alendronate
- Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With OsteoporosisCompletedPhase 3AmgenNCT01631214Written as Alendronate
- Evaluation, the Histomorphometric Study of Nanocrystalline Hydroxyapatite (Nano Bone) Wif Alendronate in the Preservation of the Tooth SocketCompletedPhase 2Islamic Azad University, SanandajNCT03980847Written as Alendronate 20 mg
- Parathyroid Hormone (PTH) With Alendronate for OsteoporosisCompletedPhase 2Helen Hayes HospitalNCT00005006Written as Alendronate
- Efficacy of Cinacalcet in the Control of Primary HyperparathyroidismCompletedPhase 4Istituto Auxologico ItalianoNCT02417389Written as Alendronate
As the comparator · 27 — what is tested is compared with Alendronate
- Bone Turnover Markers and Treatment Efficacy in Postmenopausal OsteoporosisCompletedNot applicableKhyber Medical University PeshawarNCT07242612Written as Alendronate, Ibandronate; Risedronate
- Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver DiseaseCompletedPhase 4Aristotle University Of ThessalonikiNCT05493761Written as Alendronate Sodium
- Romosozumab Effects on Bone Density, Muscle Mass, and Spine Surgery OutcomesWithdrawnPhase 2University of PittsburghNCT06973109Written as Alendronate (Fosamax)
- A Phase II Trial of RAB001 (LLP2A-Alendronate) for Steroid-Induced Early-Stage Osteonecrosis of the Femoral HeadActive, not recruitingPhase 2ZhongShan LaiBo RuiChen BioMedicine Co.,Ltd.NCT07471880Written as Alendronate (Fosamax)
- To Evaluate the Efficacy and Safety of SAL056 for Postmenopausal Women With Osteoporosis at High Fracture RiskCompletedPhase 3Shenzhen Salubris Pharmaceuticals Co., Ltd.NCT07028320Written as Alendronate
- Denosumab vs Alendronate After VertebroplastyStatus unknownNot applicableShenzhen People's HospitalNCT05662358Written as Alendronate
- Efficacy and Safety of Minodronate in Patients With Low Back PainStatus unknownPhase 4Peking University Third HospitalNCT05645289Written as Alendronate
- Romosozumab (AMG 785) in Postmenopausal Women With Low Bone Mineral DensityCompletedPhase 2AmgenNCT00896532Written as Alendronate
- Efficacy and Safety of JMT103 in the Treatment of Glucocorticoid Induced OsteoporosisStatus unknownPhase 2Shanghai JMT-Bio Inc.NCT05397938Written as Alendronate sodium
- Phase IV Clinical Trial to Evaluate Efficacy and Safety of MASI BONE S (Alendronate Sodium Trihydrate) in Postmenopausal Women With OsteoporosisStatus unknownPhase 4Yonsei UniversityNCT05387200Written as Fosamax
- 99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and OsteoporosisCompletedNot applicableXinhua Hospital, Shanghai Jiao Tong University School of MedicineNCT02304757Written as Fosamax
- Osteoporosis Treatment in Post-menopausal WomenStatus unknownPhase 4Taichung Veterans General HospitalNCT03006003Written as Alendronate
- A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis.TerminatedPhase 2GlaxoSmithKlineNCT00471237Written as Alendronate
- Effects of Genistein Aglycone in Glucocorticoid Induced OsteoporosisStatus unknownPhase 2/3University of MessinaNCT03040531Written as Alendronate Oral Tablet
- MK-5442 in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With an Oral Bisphosphonate (MK-5442-012)CompletedPhase 2Merck Sharp & Dohme LLCNCT00996801Written as Alendronate Sodium
- Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Alendronate (MK-0822-050)WithdrawnPhase 3Merck Sharp & Dohme LLCNCT01552122Written as Alendronate
- The Forteo Alendronate Comparator TrialCompletedPhase 4Eli Lilly and CompanyNCT02416271Written as Alendronate
- Denosumab Fracture Intervention Randomized Placebo Controlled Trial in Japanese Patients With OsteoporosisCompletedPhase 3Daiichi Sankyo Co., Ltd.NCT00680953Written as Alendronate sodium hydrate
- RA Denosumab on Bone Microstructure StudyCompletedPhase 4Chinese University of Hong KongNCT01770106Written as Alendronate
- A Multicenter, Randomized Placebo Controlled Pilot MicroCT Study to Estimate the Effect of Treatment With Denosumab (AMG 162) and Alendronate Sodium in Postmenopausal Women With Low Bone Mineral DensityCompletedPhase 2AmgenNCT00293813Written as Alendronate
Showing 20 of 27.
Codes
What other systems call Alendronate · ClinicalTrials.gg INT008701
- MeSH (NLM) D019386AlendronateConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 2UY4M2U3RAALENDRONATE SODIUMConfirmed FDA, NLM, Wikidata
- RxNorm 203152Confirmed FDA, Wikidata
- Wikidata Q27105722alendronate sodium trihydrateConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C973Alendronate SodiumConfirmed FDA, Wikidata
- DrugBank DBSALT000315One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D019386 | Alendronate | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 2UY4M2U3RA | ALENDRONATE SODIUM | Confirmed FDA, NLM, Wikidata |
| RxNorm | 203152 | — | Confirmed FDA, Wikidata |
| Wikidata | Q27105722 | alendronate sodium trihydrate | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C973 | Alendronate Sodium | Confirmed FDA, Wikidata |
| DrugBank | DBSALT000315 | — | One source Wikidata |
Also registered as alendronic acid (UNII X1J18R4W8P · RxNorm 236083).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.